在低资源环境中设计全国快速疫苗覆盖率调查:刚果民主共和国的经验 2018-2023

IF 4.5 3区 医学 Q2 IMMUNOLOGY Vaccine Pub Date : 2025-03-02 DOI:10.1016/j.vaccine.2025.126956
Eric M. Mafuta , Aimée M. Lulebo , Jean-Bosco N. Kasonga , Nono M. Mvuama , Christophe L. Luhata , Nicole A. Hoff , Dalau M. Nkamba , Sydney Merritt , John Samuel Otomba , Branly K. Mbunga , Aimé M.W.B. Cikomola , Anne W. Rimoin , Jean-Crispin Mukendi , Jean Bernard LeGargasson , Cyril Nogier , Léon Kinuani , Marcellin Mengouo Nimpa , Daniel K. Ishoso , Adèle N. Mudipanu , Deo Manirakiza , Paul-Samson D. Lusamba
{"title":"在低资源环境中设计全国快速疫苗覆盖率调查:刚果民主共和国的经验 2018-2023","authors":"Eric M. Mafuta ,&nbsp;Aimée M. Lulebo ,&nbsp;Jean-Bosco N. Kasonga ,&nbsp;Nono M. Mvuama ,&nbsp;Christophe L. Luhata ,&nbsp;Nicole A. Hoff ,&nbsp;Dalau M. Nkamba ,&nbsp;Sydney Merritt ,&nbsp;John Samuel Otomba ,&nbsp;Branly K. Mbunga ,&nbsp;Aimé M.W.B. Cikomola ,&nbsp;Anne W. Rimoin ,&nbsp;Jean-Crispin Mukendi ,&nbsp;Jean Bernard LeGargasson ,&nbsp;Cyril Nogier ,&nbsp;Léon Kinuani ,&nbsp;Marcellin Mengouo Nimpa ,&nbsp;Daniel K. Ishoso ,&nbsp;Adèle N. Mudipanu ,&nbsp;Deo Manirakiza ,&nbsp;Paul-Samson D. Lusamba","doi":"10.1016/j.vaccine.2025.126956","DOIUrl":null,"url":null,"abstract":"<div><div>In the Democratic Republic of the Congo (DRC), estimating vaccine coverage (VC) has traditionally relied on large-scale surveys such as the Demographic and Health Surveys (DHS) and the Multiple Indicator Cluster Surveys (MICS). However, these surveys are infrequent, costly, and lack the granularity needed for decision-making at the health district or zone (HZ) level. This paper describes the development by the Kinshasa School of Public Health (KSPH), and technical partners of a Vaccine Coverage Survey (KSPH VCS), adapted from the World Health Organization (WHO) guidelines, which aims to provides timely, cost-effective, and representative estimates of VC at the HZ level.</div><div>The KSPH VCS adopted a cross-sectional design and a multi-stage sampling approach to sample households at the HZ level. It uses Health Area as cluster in spite of Enumeration Area, and extends the eligibility age range from 12 -23 months to 6–23 months. The sample size for each HZ was calculated using vaccine coverage provided in MICS-2018. It integrates assessments of barriers and enablers to vaccination. Since 2023, it has included malaria indicators. Since its inception in 2018, it has expanded nationwide, covering all 26 provinces of the DRC by 2022.</div><div>Findings from the KSPH VCS provides estimates at the HZ level that could be combined to provincial and national estimates. Results have been instrumental in evaluating national immunization strategies, including the Mashako Plan and informing Presidential Forums on immunization. They have informed resource allocation, operational planning, and policy decisions at both national and provincial levels as they provided granularity needed for operational decision-making at the HZ level. Its results have also contributed to global immunization estimates, including the WHO/UNICEF Estimates of National Immunization Coverage (WUENIC).</div><div>The KSPH VCS demonstrates the feasibility of a locally led, cost-effective, and adaptable VC survey in a low-resource setting. Its success highlights the potential for similar methodologies to be implemented in other low- and middle-income countries seeking to improve immunization monitoring and health system performance.</div></div>","PeriodicalId":23491,"journal":{"name":"Vaccine","volume":"53 ","pages":"Article 126956"},"PeriodicalIF":4.5000,"publicationDate":"2025-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Designing a National Rapid Vaccine Coverage Survey in low-resource settings: Experiences from the Democratic Republic of the Congo 2018–2023\",\"authors\":\"Eric M. Mafuta ,&nbsp;Aimée M. Lulebo ,&nbsp;Jean-Bosco N. Kasonga ,&nbsp;Nono M. Mvuama ,&nbsp;Christophe L. Luhata ,&nbsp;Nicole A. Hoff ,&nbsp;Dalau M. Nkamba ,&nbsp;Sydney Merritt ,&nbsp;John Samuel Otomba ,&nbsp;Branly K. Mbunga ,&nbsp;Aimé M.W.B. Cikomola ,&nbsp;Anne W. Rimoin ,&nbsp;Jean-Crispin Mukendi ,&nbsp;Jean Bernard LeGargasson ,&nbsp;Cyril Nogier ,&nbsp;Léon Kinuani ,&nbsp;Marcellin Mengouo Nimpa ,&nbsp;Daniel K. Ishoso ,&nbsp;Adèle N. Mudipanu ,&nbsp;Deo Manirakiza ,&nbsp;Paul-Samson D. Lusamba\",\"doi\":\"10.1016/j.vaccine.2025.126956\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>In the Democratic Republic of the Congo (DRC), estimating vaccine coverage (VC) has traditionally relied on large-scale surveys such as the Demographic and Health Surveys (DHS) and the Multiple Indicator Cluster Surveys (MICS). However, these surveys are infrequent, costly, and lack the granularity needed for decision-making at the health district or zone (HZ) level. This paper describes the development by the Kinshasa School of Public Health (KSPH), and technical partners of a Vaccine Coverage Survey (KSPH VCS), adapted from the World Health Organization (WHO) guidelines, which aims to provides timely, cost-effective, and representative estimates of VC at the HZ level.</div><div>The KSPH VCS adopted a cross-sectional design and a multi-stage sampling approach to sample households at the HZ level. It uses Health Area as cluster in spite of Enumeration Area, and extends the eligibility age range from 12 -23 months to 6–23 months. The sample size for each HZ was calculated using vaccine coverage provided in MICS-2018. It integrates assessments of barriers and enablers to vaccination. Since 2023, it has included malaria indicators. Since its inception in 2018, it has expanded nationwide, covering all 26 provinces of the DRC by 2022.</div><div>Findings from the KSPH VCS provides estimates at the HZ level that could be combined to provincial and national estimates. Results have been instrumental in evaluating national immunization strategies, including the Mashako Plan and informing Presidential Forums on immunization. They have informed resource allocation, operational planning, and policy decisions at both national and provincial levels as they provided granularity needed for operational decision-making at the HZ level. Its results have also contributed to global immunization estimates, including the WHO/UNICEF Estimates of National Immunization Coverage (WUENIC).</div><div>The KSPH VCS demonstrates the feasibility of a locally led, cost-effective, and adaptable VC survey in a low-resource setting. Its success highlights the potential for similar methodologies to be implemented in other low- and middle-income countries seeking to improve immunization monitoring and health system performance.</div></div>\",\"PeriodicalId\":23491,\"journal\":{\"name\":\"Vaccine\",\"volume\":\"53 \",\"pages\":\"Article 126956\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-03-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vaccine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0264410X25002531\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0264410X25002531","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Designing a National Rapid Vaccine Coverage Survey in low-resource settings: Experiences from the Democratic Republic of the Congo 2018–2023
In the Democratic Republic of the Congo (DRC), estimating vaccine coverage (VC) has traditionally relied on large-scale surveys such as the Demographic and Health Surveys (DHS) and the Multiple Indicator Cluster Surveys (MICS). However, these surveys are infrequent, costly, and lack the granularity needed for decision-making at the health district or zone (HZ) level. This paper describes the development by the Kinshasa School of Public Health (KSPH), and technical partners of a Vaccine Coverage Survey (KSPH VCS), adapted from the World Health Organization (WHO) guidelines, which aims to provides timely, cost-effective, and representative estimates of VC at the HZ level.
The KSPH VCS adopted a cross-sectional design and a multi-stage sampling approach to sample households at the HZ level. It uses Health Area as cluster in spite of Enumeration Area, and extends the eligibility age range from 12 -23 months to 6–23 months. The sample size for each HZ was calculated using vaccine coverage provided in MICS-2018. It integrates assessments of barriers and enablers to vaccination. Since 2023, it has included malaria indicators. Since its inception in 2018, it has expanded nationwide, covering all 26 provinces of the DRC by 2022.
Findings from the KSPH VCS provides estimates at the HZ level that could be combined to provincial and national estimates. Results have been instrumental in evaluating national immunization strategies, including the Mashako Plan and informing Presidential Forums on immunization. They have informed resource allocation, operational planning, and policy decisions at both national and provincial levels as they provided granularity needed for operational decision-making at the HZ level. Its results have also contributed to global immunization estimates, including the WHO/UNICEF Estimates of National Immunization Coverage (WUENIC).
The KSPH VCS demonstrates the feasibility of a locally led, cost-effective, and adaptable VC survey in a low-resource setting. Its success highlights the potential for similar methodologies to be implemented in other low- and middle-income countries seeking to improve immunization monitoring and health system performance.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Vaccine
Vaccine 医学-免疫学
CiteScore
8.70
自引率
5.50%
发文量
992
审稿时长
131 days
期刊介绍: Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.
期刊最新文献
Assessing the geographic and socioeconomic determinants of vaccine coverage in Ethiopia: A spatial and multistage analysis at the district level Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses against the JN.1 sublineages of SARS-CoV-2 in mice Associated factors for dropout of first versus third doses of pentavalent vaccination in Tanzania Cost-effectiveness analysis of 21-valent pneumococcal conjugated vaccine among adults in Canada
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1